In 206 adults with BMI 35 or more randomised to recombinant or egg-based standard-dose influenza vaccine, day-28 HAI GMT ratios favoured recombinant for A/H1N1 (1.6), A/H3N2 (2.0) and B/Yamagata (1.3) but not B/Victoria (0.9); titres did not differ by day 180.
RCTn = 206
Loubet et al. Recombinant vs Standard Influenza Vaccine in Adults With Severe Obesity: A Randomized Clinical Trial